Charming Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Nov '25 Nov 11, 2025	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023
Market Cap	504	504	-	-	-
Market Cap Growth	-	-	-	-	-
Enterprise Value	502.48	498.63	0	0	0
Last Close Price	29.11	29.36	-	-	-
PS Ratio	104.89	104.89	-	-	-
PB Ratio	97.33	97.33	-	-	-
P/TBV Ratio	90.74	91.51	-	-	-
EV/Sales Ratio	104.51	103.72	-	-	-
EV/EBITDA Ratio	2689.39	2668.81	-	-	-
Debt / Equity Ratio	0.10	0.10	13.65	-0.52	-0.85
Debt / EBITDA Ratio	4.86	4.86	0.70	0.69	-
Debt / FCF Ratio	-	-	8.39	11.33	0.99
Net Debt / Equity Ratio	-1.09	-1.09	-32.51	1.06	0.10
Net Debt / EBITDA Ratio	-30.12	-30.12	-0.97	-0.82	0.39
Net Debt / FCF Ratio	3.62	3.62	-11.57	-13.46	-0.06
Asset Turnover	0.49	0.63	1.22	1.07	0.55
Inventory Turnover	1.37	1.34	0.56	0.24	0.26
Quick Ratio	1.56	1.56	0.64	0.57	0.55
Current Ratio	1.89	1.89	0.68	0.62	0.57
Return on Equity (ROE)	-0.44%	-0.87%	-218.65%	-68.06%	26.45%
Return on Assets (ROA)	0.05%	0.07%	22.67%	14.67%	-6.52%
Return on Capital Employed (ROCE)	-0.53%	-0.98%	-470.39%	-113.20%	66.45%
Buyback Yield / Dilution	-5.29%	-5.29%	99.90%	0.00%	-
Total Shareholder Return	-5.29%	-5.29%	99.90%	0.00%	-

SEC Filings: 10-K · 10-Q